Your browser doesn't support javascript.
loading
Omalizumab in chronic spontaneous urticaria: A real-life experience of dose and intervals adjustments in Belgium.
de Montjoye, Laurence; Herman, Anne; Dumoutier, Laure; Lambert, Michel; Tromme, Isabelle; Baeck, Marie.
Afiliación
  • de Montjoye L; Department of Dermatology, Cliniques universitaires Saint-Luc, Institute of Experimental and Clinical Research, Pneumology, ENT and Dermatology Pole, Université catholique de Louvain, Brussels, Belgium. Electronic address: laurence.demontjoye@uclouvain.be.
  • Herman A; Department of Dermatology, Cliniques universitaires Saint-Luc, Institute of Experimental and Clinical Research, Pneumology, ENT and Dermatology Pole, Université catholique de Louvain, Brussels, Belgium.
  • Dumoutier L; De Duve Institute, Université catholique de Louvain, Brussels, Belgium.
  • Lambert M; Department of Internal Medecine, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.
  • Tromme I; Department of Dermatology, Cliniques universitaires Saint-Luc, Institute of Experimental and Clinical Research, Pneumology, ENT and Dermatology Pole, Université catholique de Louvain, Brussels, Belgium.
  • Baeck M; Department of Dermatology, Cliniques universitaires Saint-Luc, Institute of Experimental and Clinical Research, Pneumology, ENT and Dermatology Pole, Université catholique de Louvain, Brussels, Belgium.
Ann Allergy Asthma Immunol ; 121(5): 620-622, 2018 11.
Article en En | MEDLINE | ID: mdl-30392532
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Urticaria / Antialérgicos / Omalizumab Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Urticaria / Antialérgicos / Omalizumab Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2018 Tipo del documento: Article